These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 25956537)
1. The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients. Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Mertz Nielsen A J Crohns Colitis; 2015 Aug; 9(8):625-32. PubMed ID: 25956537 [TBL] [Abstract][Full Text] [Related]
2. Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis. Theede K; Holck S; Ibsen P; Ladelund S; Nordgaard-Lassen I; Nielsen AM Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1929-36.e1. PubMed ID: 26051392 [TBL] [Abstract][Full Text] [Related]
3. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study. Voiosu T; Benguş A; Dinu R; Voiosu AM; Bălănescu P; Băicuş C; Diculescu M; Voiosu R; Mateescu B J Gastrointestin Liver Dis; 2014 Sep; 23(3):273-8. PubMed ID: 25267955 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count. Nakarai A; Kato J; Hiraoka S; Inokuchi T; Takei D; Moritou Y; Akita M; Takahashi S; Hori K; Harada K; Okada H; Yamamoto K World J Gastroenterol; 2014 Dec; 20(48):18367-74. PubMed ID: 25561804 [TBL] [Abstract][Full Text] [Related]
5. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies? Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077 [TBL] [Abstract][Full Text] [Related]
6. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings. Iacucci M; Fort Gasia M; Hassan C; Panaccione R; Kaplan GG; Ghosh S; Gui X Endoscopy; 2015 Aug; 47(8):726-34. PubMed ID: 25826276 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test. Nakarai A; Kato J; Hiraoka S; Kuriyama M; Akita M; Hirakawa T; Okada H; Yamamoto K Am J Gastroenterol; 2013 Jan; 108(1):83-9. PubMed ID: 23007005 [TBL] [Abstract][Full Text] [Related]
8. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Walsh A; Palmer R; Travis S Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):367-78. PubMed ID: 24975528 [TBL] [Abstract][Full Text] [Related]
9. Potential utility of a new ulcerative colitis segmental endoscopic index combining disease severity and the extent of inflammation. Suzuki Y; Uchiyama K; Kato M; Matsuo K; Nakagawa T; Kishikawa H; Kimura N; Kasanuki J; Ino S J Clin Gastroenterol; 2015; 49(5):401-6. PubMed ID: 25127112 [TBL] [Abstract][Full Text] [Related]
10. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Irvine EJ; Zhou Q; Thompson AK Am J Gastroenterol; 1996 Aug; 91(8):1571-8. PubMed ID: 8759664 [TBL] [Abstract][Full Text] [Related]
11. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis. Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study. Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390 [TBL] [Abstract][Full Text] [Related]
13. Mucosal Healing in Ulcerative Colitis--When Zero is Better. Boal Carvalho P; Dias de Castro F; Rosa B; Moreira MJ; Cotter J J Crohns Colitis; 2016 Jan; 10(1):20-5. PubMed ID: 26438714 [TBL] [Abstract][Full Text] [Related]
14. The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis. Aniwan S; Bruining DH; Park SH; Al-Bawardy B; Kane SV; Coelho Prabhu N; Kisiel JB; Raffals LE; Papadakis KA; Pardi DS; Tremaine WJ; Loftus EV J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31387259 [TBL] [Abstract][Full Text] [Related]
15. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial. Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351 [TBL] [Abstract][Full Text] [Related]
16. The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine. Yarlas A; Willian MK; Nag A Qual Life Res; 2021 Jul; 30(7):1925-1938. PubMed ID: 33651279 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis. Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993 [TBL] [Abstract][Full Text] [Related]
18. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life. Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063 [TBL] [Abstract][Full Text] [Related]
19. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity. Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429 [TBL] [Abstract][Full Text] [Related]